# The Safety and Immunogenicity Research of Live Attenuated Varicella Vaccine After the 2 Doses Vaccination

> **NCT01866566** · PHASE4 · UNKNOWN · sponsor: **Beijing Center for Disease Control and Prevention** · enrollment: 1800 (estimated)

## Conditions studied

- Varicella

## Interventions

- **BIOLOGICAL:** HBV-3
- **BIOLOGICAL:** HBV-6
- **BIOLOGICAL:** varicella-3
- **BIOLOGICAL:** varicella-6

## Key facts

- **NCT ID:** NCT01866566
- **Lead sponsor:** Beijing Center for Disease Control and Prevention
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-06
- **Primary completion:** 2014-01
- **Final completion:** 2016-01
- **Target enrollment:** 1800 (ESTIMATED)
- **Last updated:** 2013-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01866566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01866566, "The Safety and Immunogenicity Research of Live Attenuated Varicella Vaccine After the 2 Doses Vaccination". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01866566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*